We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$29.4B
AUM Growth
-$873M
(-2.9%)
Cap. Flow
+$534M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.48% |
| 2 | Healthcare | 13.67% |
| 3 | Financials | 9.64% |
| 4 | Industrials | 8.71% |
| 5 | Consumer Discretionary | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Tonix Pharmaceuticals
TNXP
$192M
| $108K | ﹤0.01% |
+10
| New | +$245K |
|
2202
XWELL
XWEL
$8.61M
| $106K | ﹤0.01% |
6,912
-30,854
| -82% | -$546K |
|
|
LCI
2203
DELISTED
Lannett Company, Inc.
LCI
| $105K | ﹤0.01% |
58,446
-44,635
| -43% | -$97.8K |
|
2204
Forte Biosciences
FBRX
$1.57B
| $104K | ﹤0.01% |
3,884
-1,008
| -21% | -$32K |
|
2205
Lexicon Pharmaceuticals
LXRX
$1.1B
| $104K | ﹤0.01% |
+43,297
| New | +$120K |
|
2206
loanDepot
LDI
$516M
| $103K | ﹤0.01% |
78,106
-103,874
| -57% | -$170K |
|
|
SNCE
2207
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $102K | ﹤0.01% |
3,166
-2,311
| -42% | -$85.7K |
|
|
AHG
2208
Akso Health Group
AHG
$1.16B
| $101K | ﹤0.01% |
111,421
-8,300
| -7% | -$8.81K |
|
2209
EyePoint Inc
EYPT
$1.2B
| $101K | ﹤0.01% |
12,825
-737
| -5% | -$6.85K |
|
2210
LG Display
LPL
$3.3B
| $101K | ﹤0.01% |
24,637
+13,237
| +116% | +$74.7K |
|
2211
Amtech Systems
ASYS
$272M
| $100K | ﹤0.01% |
11,800
-3,400
| -22% | -$31.3K |
|
2212
Westwater Resources
WWR
$97.5M
| $100K | ﹤0.01% |
87,934
-43,655
| -33% | -$56.6K |
|
|
SFR
2213
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
| $100K | ﹤0.01% |
+10,000
| New | +$99.1K |
|
2214
BARK
BARK
$101M
| $99K | ﹤0.01% |
2,719
-21,418
| -89% | -$792K |
|
|
BGMS
2215
Bio Green Med Solution Inc
BGMS
$5.24M
| $98K | ﹤0.01% |
+19
| New | +$96.5K |
|
|
WHLM
2216
DELISTED
Wilhelmina International, Inc
WHLM
| $98K | ﹤0.01% |
23,927
-800
| -3% | -$3.65K |
|
|
TBIO
2217
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $98K | ﹤0.01% |
+3,272
| New | +$115K |
|
|
KVSC
2218
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $98K | ﹤0.01% |
+10,000
| New | +$97.9K |
|
2219
Tenaya Therapeutics
TNYA
$163M
| $97K | ﹤0.01% |
+33,299
| New | +$155K |
|
2220
Clene
CLNN
$67.5M
| $94K | ﹤0.01% |
+1,670
| New | +$111K |
|
|
TRML
2221
DELISTED
Tourmaline Bio
TRML
| $93K | ﹤0.01% |
+3,518
| New | +$128K |
|
2222
Twin Vee PowerCats
VEEE
$4.85M
| $93K | ﹤0.01% |
+103
| New | +$150K |
|
|
SY
2223
So-Young International
SY
$219M
| $92K | ﹤0.01% |
127,467
-86,687
| -40% | -$77K |
|
|
ZYNE
2224
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $90K | ﹤0.01% |
+122,662
| New | +$139K |
|
2225
Curis
CRIS
$7.83M
| $89K | ﹤0.01% |
317
-2,781
| -90% | -$1.12M |
|
Similar funds
VAM
Two Sigma Investments's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Investments held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Two Sigma Investments's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Two Sigma Investments's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- Two Sigma Investments added most to GSK in Q3 2022, an estimated $223M increase.
- Two Sigma Investments's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- Two Sigma Investments fully exited Bank of America in Q3 2022, selling an estimated $225M.
- Two Sigma Investments's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- Two Sigma Investments opened 582 new positions and closed 600 in Q3 2022.
- Two Sigma Investments's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.